Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 12,819 results that match your search.12,819 results
  • We have previously discussed Myanmar's new law on trademarks. It should also be noted that the same law is also the primary legislation on the protection of geographical indications (GIs) in Myanmar. Chapter 16 (Sections 53 to 60) of the Pyidaungsu Hluttaw Law No. 3 of 2019, fully titled the Trademark and Geographical Indications Law (TGIL), deals exclusively with GIs, and this is our summary of its contents, as well as our recommendations for those interested in registering GIs in Myanmar under the TGIL.
  • Sponsored by Hanol IP & Law
    Precision medicine, also known as personalised medicine, is an emerging field in healthcare and seems to have a promising future as it accounts for 42% of new molecular entities which the Food and Drug Administration (FDA) approved in 2018. Since precision medicine aims to provide bespoke medical treatments based on individual patient's characteristics, it essentially incorporates diagnosis and treatment methods. Under Korean patent law and practice, treatment and diagnosis methods are not considered patent eligible subject matter. As such, it is necessary to circumvent restrictive eligibility requirements to obtain protection for precision medicines in Korea. In the past, although precision medicines can be pursued as a pharmaceutical/diagnostic composition claim, it was not easy to claim methodological aspects of precision medicines (e.g. dosage regimen) which were not considered as technical features constituting composition itself (Supreme Court decisions 2007Hu2926 and 2007Hu2933, rendered on May 28 2009).
  • Foreign applications for trademarks and designs are on the up, according to the UKIPO’s annual report, which also shows a decline in patent applications and a focus on workplace wellbeing
  • Nigel Swycher, CEO of patent analysis software company Cipher, looks ahead to the IP Corporate Strategy Summit 2019
  • In-house counsel consider whether a new IP right for software inventions could help the UK compete after Brexit and discuss whether IP is enough of a priority for decision makers
  • Airbus, Huawei and a medical device company say they would like to see German judges consider the value of patents and preliminary enforceability more carefully before they issue injunctions
  • WIPO’s annual World Intellectual Property Indicators report reveals that soaring demand in China drove worldwide filing growth for patents, trade marks and industrial designs
  • With Amazon launching a pilot patent evaluation programme for take-down actions, companies say the system looks useful but that it should only be used for matters that do not require discovery or the possibility for appeal
  • Recently, many disputes regarding store appearances have occurred relating to businesses, such as sushi or ramen stores. Unlike the US where the trade dress theory exists, rules for protecting store appearance in Japan are not set and no case law has ever granted an injunction. This is the first case granting an injunction in a store appearance case.
  • Ordnance Survey, the national mapping agency for Great Britain, is in court this week to defend a case in which IP and database rights are at issue